ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 31 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3 | -99.9% | 1,666 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 1,666 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -33.3% | 1,666 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | -14.3% | 1,666 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -30.0% | 1,666 | 0.0% | 0.00% | – |
Q3 2021 | $10,000 | -23.1% | 1,666 | 0.0% | 0.00% | – |
Q2 2021 | $13,000 | -23.5% | 1,666 | 0.0% | 0.00% | – |
Q1 2021 | $17,000 | – | 1,666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 245,000 | $676,000 | 0.76% |
BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |